Pathologically, MS lesions are characterized by the presence of CD4 and CD8 T cells, as well as macrophages, where CD4 T cells appears to be predominant in acute lesions and CD8 T cells more apparent in chronic lesions (Fletcher et al. 2010; van Langelaar et al. 2020). This evidence concerns the gene CD8A and myeloid sarcoma.